BioGenerator Ventures — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Agragene develops Precision-Guided Sterile Insect Technology (pgSIT) marketed as KNOCKOUT™, a biocontrol product for controlling crop insect pests such as Spotted Wing Drosophila while reducing reliance on traditional insecticides.
AgTechBiotechClimate TechSan Diego, US
Bryan Witherbee(President and CEO)inTracy Ellis(Executive Officer)Clyde Shores(Executive Officer, Director)Robert Schmidt(Director)Gordon Alton(Executive Officer, Director)David Webb(Director)
Co-investorsMissouri Technology CorporationOspraie Ag Science
Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types.
AI & Machine LearningBiotechDeep TechHealthtechSaint Louis, US
Edward Weinstein(Executive Officer, Director)inTom Cohen(Executive Officer)inGary J. Patti, Ph.D.(Founder; Chief Scientific Advisor)Dave Smoller, Ph.D.(Co-Founder)Edward Weinstein, Ph.D.(Chief Executive Officer)
BoardDavid Smoller(Director)in
Co-investorsTelegraph Hill PartnersCultivation Capital
RevivBio uses protein engineering and advanced microfluidics to develop biotechnology products.
BiotechDeep TechFrederick, US
Fatemeh Aileen Mastouri(Executive Officer, Director)
Co-investorsAlumni VenturesSeventure Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








